MIRA INFORM REPORT

 

 

Report Date :

27.03.2014

 

IDENTIFICATION DETAILS

 

Name :

NORBROOK LABORATORIES (IRELAND) LIMITED 

 

 

Registered Office :

Rossmore Industrial Estate, Monaghan 486816

 

 

Country :

Ireland

 

 

Financials (as on) :

03.08.2012

 

 

Date of Incorporation :

08.01.1980

 

 

Com. Reg. No.:

IE073011

 

 

Legal Form :

Private limited with Share Capital

 

 

Line of Business :

Manufacturer of pharmaceutical products

 

 

No. of Employees

Not Available 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

No Complaints 

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – december 01, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Ireland

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Ireland ECONOMIC OVERVIEW

 

Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity has dropped sharply since the onset of the world financial crisis, with GDP falling by over 3% in 2008, nearly 7% in 2009, and less than 1% in 2010. Ireland entered into a recession in 2008 for the first time in more than a decade, with the subsequent collapse of its domestic property and construction markets. Property prices rose more rapidly in Ireland in the decade up to 2007 than in any other developed economy. Since their 2007 peak, average house prices have fallen 47%. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become a key component of Ireland's economy. Agriculture, once the most important sector, is now dwarfed by industry and services. In 2008 the former COWEN government moved to guarantee all bank deposits, recapitalize the banking system, and establish partly-public venture capital funds in response to the country's economic downturn. In 2009, in continued efforts to stabilize the banking sector, the Irish Government established the National Asset Management Agency (NAMA) to acquire problem commercial property and development loans from Irish banks. Faced with sharply reduced revenues and a burgeoning budget deficit, the Irish Government introduced the first in a series of draconian budgets in 2009. In addition to across-the-board cuts in spending, the 2009 budget included wage reductions for all public servants. These measures were not sufficient. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP - because of additional government support for the banking sector. In late 2010, the former COWEN government agreed to a $112 billion loan package from the EU and IMF to help Dublin further increase the capitalization of its banking sector and avoid defaulting on its sovereign debt. Since entering office in March 2011, the new KENNY government has intensified austerity measures to try to meet the deficit targets under Ireland's EU-IMF program. Ireland achieved moderate growth of 1.4% in 2011 and cut the budget deficit to 9.1% of GDP. Although the recovery slowed in 2012 because of weaker EU demand for Irish exports, Dublin managed to trim the deficit to about 8.5% of GDP.

 

Source : CIA

 

 

 

 

 


REGISTERED NAME & COMPANY SUMMARY

 

Company Name

NORBROOK LABORATORIES (IRELAND) LIMITED

Company Number

IE073011

Registered Address

ROSSMORE INDUSTRIAL ESTATE
MONAGHAN
486816

Operating Address

Newry, bt35 6qq, Northern Ireland

Website Address

-

 

 

Telephone Number

0862538973

 

 

TPS

No

 

 

Incorporation Date

08/01/1980

Company Status

Active - Accounts Filed

Previous Name

 

Type

Private limited with Share Capital

Date of Change

-

Filing Date of Accounts

-

Principal Activity

Manufacturer of pharmaceutical products

 

DIRECTORS/MANAGEMENT

 

Total Current Directors

3

Total Current Secretaries

1

Total Previous Directors / Company Secretaries

1

 

Current Directors

Name

MARTIN PATRICK MURDOCK

Date of Birth

25/02/1962

Officers Title

 

Nationality

 

Present Appointments

8

Function

Director

Appointment Date

02/06/1997

 

 

Address

15 WELL ROAD, WARRENPOINT, NEWRY, CO.DOWN BT34 3RS

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

LORD BALLYEDMOND

Date of Birth

05/01/1944

Officers Title

 

Nationality

 

Present Appointments

8

Function

Director

Appointment Date

14/08/1980

 

 

Address

BALLYEDMOND CASTLE, ROSTREVOR, CO. DOWN, BT34 3AG

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

PATRICK FINTAN HUGHES

Date of Birth

07/02/1956

Officers Title

 

Nationality

 

Present Appointments

6

Function

Director

Appointment Date

13/04/2001

 

 

Address

4 PINEVIEW, COMMONS ROAD, NAVAN, CO. MEATH

 

NEGATIVE INFORMATION

 

CJ

Total Number of Exact CJs -

0

Total Value of Exact CJs -

€0

Total Number of Possible CJs -

0

Total Value of Possible CJs -

€0

Total Number of Satisfied CJs -

0

Total Value of Satisfied CJs -

€0

 

Exact CJ Details

There are no exact CJ details


Possible CJ Details

There are no possible CJ details

Writ Details

There are no writ details

 

Mortgage Summary

Outstanding

2

Satisfied

1

 

SHARE & SHARE CAPITAL INFORMATION

 

Share Capital

€3

 

Top 20 Shareholders

Name

Currency

Share Count

Share Type

Nominal Value

LORD BALLYMOND

EUR

1

ORDINARY

1.27

NORBROOK LABORATORIES LTD

EUR

1

ORDINARY

1.27

 

PAYMENT INFORMATION

 

Payment Information Summary

Days Beyond Terms

Trend Indicator

                         Average Payment Experience  

 

 

N/A

29

Company DBT

UK Average DBT

Steady

   

Improving Worsening

Be the first to leave a payment experience
for this company


Within Terms 91+ Days

 

 


GROUP STRUCTURE & AFFILIATED COMPANIES

 

Statistics

Group

11 companies

Linkages

0 companies

Countries

In 0 countries

 

Summary

Holding Company

NORBROOK LABORATORIES LIMITED

Ownership Status

Intermediately Owned

Ultimate Holding Company

NORBROOK HOLDINGS LIMITED

 

Group structure

Company Name

 

Registered Number

Latest Key Financials

Consol. Accounts

Turnover

NORBROOK HOLDINGS LIMITED

 

02258447

03.08.2012

Y

£191,706,584

NORBROOK HOLDINGS B.V.

 

33204983

31.07.2011

N

 

NORBROOK MANUFACTURI...

 

IE128703

03.08.2012

N

 

NORBROOK LABORATORIES...

 

NI007665

03.08.2012

Y

£180,657,720

NORBROOK EXPORTS LIM...

 

NI032757

31.07.2012

N

 

CORBY INVESTMENTS LI...

 

03425483

03.08.2012

N

 

HAUGHEY AIR LIMITED

 

NI027648

03.08.2012

N

 

NORBROOK LABORATORIE...

 

IE073011

03.08.2012

N

 

NORBROOK LABORATORIE...

 

01778942

03.08.2012

N

 

NORBROOK LABORATORIE...

 

NI014172

31.07.2012

N

 

BALLYEDMOND CASTLE F...

 

NI017640

03.08.2012

N

 

 

FINANCIAL INFORMATION

 

Key Financials

Year to Date

Turnover

Pre Tax Profit

Shareholder Funds

Employees

03/08/2012

-

-

€12,143,671

-

29/07/2011

-

-

€9,823,176

-

31/07/2010

-

-

€7,781,288

-

 

Profit & Loss

Date Of Accounts

03/08/12

(%)

29/07/11

(%)

31/07/10

(%)

31/07/09

(%)

01/08/08

Weeks

53

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Turnover

-

-

-

-

-

-

-

-

-

Export

-

-

-

-

-

-

-

-

-

Cost of Sales

-

-

-

-

-

-

-

-

-

Gross Profit

-

-

-

-

-

-

-

-

-

Wages & Salaries

-

-

-

-

-

-

-

-

-

Directors Emoluments

-

-

-

-

-

-

-

-

-

Operating Profit

-

-

-

-

-

-

-

-

-

Depreciation

€23,116

5.8%

€21,839

31.8%

€16,570

-2.4%

€16,969

-3.1%

€17,514

Audit Fees

-

-

-

-

-

-

-

-

-

Interest Payments

-

-

-

-

-

-

-

-

-

Pre Tax Profit

-

-

-

-

-

-

-

-

-

Taxation

-

-

-

-

-

-

-

-

-

Profit After Tax

-

-

-

-

-

-

-

-

-

Dividends Payable

-

-

-

-

-

-

-

-

-

Retained Profit

-

-

-

-

-

-

-

-

-

 

Balance Sheet

Date Of Accounts

03/08/12

(%)

29/07/11

(%)

31/07/10

(%)

31/07/09

(%)

01/08/08

Tangible Assets

€10,856,375

21.9%

€8,902,490

41.7%

€6,283,601

33.9%

€4,693,370

17.9%

€3,981,524

Intangible Assets

0

-

0

-

0

-

0

-

0

Total Fixed Assets

€10,856,375

21.9%

€8,902,490

41.7%

€6,283,601

33.9%

€4,693,370

17.9%

€3,981,524

Stock

€1,821,124

22.5%

€1,487,178

-20.8%

€1,878,292

28.3%

€1,463,430

-10.8%

€1,639,925

Trade Debtors

€2,369,433

-1.4%

€2,402,256

0.5%

€2,389,161

13.7%

€2,101,271

-6.1%

€2,238,711

Cash

0

-

0

-

0

-

0

-

0

Other Debtors

€58,240

1.3%

€57,489

49.1%

€38,558

28.1%

€30,098

-47%

€56,761

Miscellaneous Current Assets

0

-

0

-

0

-

0

-

0

Total Current Assets

€4,248,797

7.6%

€3,946,923

-8.3%

€4,306,011

19.8%

€3,594,799

-8.7%

€3,935,397

Trade Creditors

€94,991

-12.1%

€108,124

-76.5%

€460,272

27%

€362,370

-9.4%

€399,887

Bank Loans & Overdrafts

€1,353,004

-25.8%

€1,823,489

3.1%

€1,769,076

98.4%

€891,876

-27.7%

€1,233,150

Other Short Term Finance

0

-

0

-

0

-

0

-

0

Miscellaneous Current Liabilities

€1,496,170

39%

€1,076,308

92.5%

€559,002

24.1%

€450,274

-16.6%

€539,601

Total Current Liabilities

€2,944,165

-2.1%

€3,007,921

7.9%

€2,788,350

63.6%

€1,704,520

-21.5%

€2,172,638

Bank Loans & Overdrafts and LTL

€1,370,340

-25.6%

€1,841,805

2.9%

€1,789,050

96.1%

€912,513

-27.3%

€1,254,664

Other Long Term Finance

0

-

0

-

0

-

0

-

0

Total Long Term Liabilities

€17,336

-5.4%

€18,316

-8.3%

€19,974

-3.2%

€20,637

-4.1%

€21,514

 

Capital & Reserves

Date Of Accounts

03/08/12

(%)

29/07/11

(%)

31/07/10

(%)

31/07/09

(%)

01/08/08

Called Up Share Capital

€3

-

€3

-

€3

-

€3

-

€3

P & L Account Reserve

€12,143,668

23.6%

€9,823,173

26.2%

€7,781,285

18.6%

€6,563,009

14.7%

€5,722,766

Revaluation Reserve

-

-

-

-

-

-

-

-

-

Sundry Reserves

-

-

-

-

-

-

-

-

-

Shareholder Funds

€12,143,671

23.6%

€9,823,176

26.2%

€7,781,288

18.6%

€6,563,012

14.7%

€5,722,769

 

Other Financial Items

Date Of Accounts

03/08/12

(%)

29/07/11

(%)

31/07/10

(%)

31/07/09

(%)

01/08/08

Net Worth

€12,143,671

23.6%

€9,823,176

26.2%

€7,781,288

18.6%

€6,563,012

14.7%

€5,722,769

Working Capital

€1,304,632

38.9%

€939,002

-38.1%

€1,517,661

-19.7%

€1,890,279

7.2%

€1,762,759

Total Assets

€15,105,172

17.6%

€12,849,413

21.3%

€10,589,612

27.8%

€8,288,169

4.7%

€7,916,921

Total Liabilities

€2,961,501

-2.1%

€3,026,237

7.8%

€2,808,324

62.8%

€1,725,157

-21.4%

€2,194,152

Net Assets

€12,143,671

23.6%

€9,823,176

26.2%

€7,781,288

18.6%

€6,563,012

14.7%

€5,722,769

 

Miscellaneous

Date Of Accounts

03/08/12

(%)

29/07/11

(%)

31/07/10

(%)

31/07/09

(%)

01/08/08

Contingent Liability

YES

-

YES

-

YES

-

YES

-

YES

Capital Employed

€12,161,007

23.6%

€9,841,492

26.2%

€7,801,262

18.5%

€6,583,649

14.6%

€5,744,283

 

Ratios

Date Of Accounts

03/08/12

29/07/11

31/07/10

31/07/09

01/08/08

Pre-tax profit margin %

-

-

-

-

-

Current ratio

1.44

1.31

1.54

2.11

1.81

Sales/Net Working Capital

-

-

-

-

-

Gearing %

11.30

18.70

23

13.90

21.90

Equity in %

80.40

76.40

73.50

79.20

72.30

Creditor Days

-

-

-

-

-

Debtor Days

-

-

-

-

-

Liquidity/Acid Test

0.82

0.81

0.87

1.25

1.05

Return On Capital Employed %

-

-

-

-

-

Return On Total Assets Employed %

-

-

-

-

-

Current Debt Ratio

0.24

0.30

0.35

0.25

0.37

Total Debt Ratio

0.24

0.30

0.36

0.26

0.38

Stock Turnover Ratio %

-

-

-

-

-

Return on Net Assets Employed %

-

-

-

-

 

 

ADDITIONAL INFORMATION

 

Auditors

KPMG

Auditor Comments

The audit report contains no adverse comments

Bankers

BANK OF IRELAND

 

Current Company Secretary

Name

MARTIN PATRICK MURDOCK

Date of Birth

25/02/1962

Officers Title

 

Nationality

 

Present Appointments

8

Function

Company Secretary

Appointment Date

01/01/1901

 

 

Address

15 WELL ROAD, WARRENPOINT, NEWRY, CO.DOWN BT34 3RS

 

Status History

No Status History found

 

Event History

Date

Description

11/06/2013

New Accounts Filed

11/06/2013

New Accounts Filed

08/06/2013

Annual Returns

19/06/2012

New Accounts Filed

19/06/2012

New Accounts Filed

16/06/2012

Annual Returns

02/06/2011

Annual Returns

02/06/2011

New Accounts Filed

13/07/2010

Annual Returns

17/06/2010

Annual Returns

17/06/2010

New Accounts Filed

23/06/2009

Annual Returns

23/06/2009

New Accounts Filed

30/06/2008

Annual Returns

30/06/2008

Annual Returns

 

Previous Company Names

No Previous Names found

 


NOTES & COMMENTS

 

Commentary

No exact match CCJs are recorded against the company.

 

There is insufficient data to indicate a change in this company's percentage of sales.

 

Net Worth increased by 23.6% during the latest trading period.

 

A 17.6% growth in Total Assets occurred during the latest trading period.

 

There is insufficient data to indicate a change in this company's pre-tax profit.

 

The audit report contains no adverse comments.

 

No recent changes in directorship are recorded.

 

The company is part of a group.

 

The company has changed its year end on multiple occasions.

 

The movement in accumulated earnings would indicate that the company made a profit after tax and other appropriations, including dividends.

 

The company was established over 34 years ago.

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.17

UK Pound

1

Rs.99.39

Euro

1

Rs.83.09

                

INFORMATION DETAILS

 

Report Prepared by :

MNL

               

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.